Advanced search
1 file | 447.53 KB

During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ

(2015) EBIOMEDICINE. 2(9). p.1153-1159
Author
Organization
Abstract
BACKGROUND: Characterising the correlates of HIV persistence improves understanding of disease pathogenesis and guides the design of curative strategies. This study investigated factors associated with integrated HIV-1 DNA load during consistently suppressive first-line antiretroviral therapy (ART). METHOD: Total, integrated, and 2-long terminal repeats (LTR) circular HIV-1 DNA, residual plasma HIV-1 RNA, T-cell activation markers, and soluble CD14 (sCD14) were measured in peripheral blood of 50 patients that had received 1-14 years of efavirenz-based or nevirapine-based therapy. RESULTS: Integrated HIV-1 DNA load (per 10(6) peripheral blood mononuclear cells) was median 1.9 log10 copies (interquartile range 1.7-2.2) and showed a mean difference of 0.2 log10 copies per 10 years of suppressive ART (95% confidence interval - 0.2, 0.6; p = 0.28). It was positively correlated with total HIV-1 DNA load and frequency of CD8(+)HLA-DR/DP/DQ(+) cells, and was also higher in subjects with higher sCD14 levels, but showed no correlation with levels of 2-LTR circular HIV-1 DNA and residual plasma HIV-1 RNA, or the frequency of CD4(+)CD38(+) and CD8(+)CD38(+) cells. Adjusting for pre-ART viral load, duration of suppressive ART, CD4 cell counts, residual plasma HIV-1 RNA levels, and sCD14 levels, integrated HIV-1 DNA load was mean 0.5 log10 copies higher for each 50% higher frequency of CD8(+)HLA-DR/DP/DQ(+) cells (95% confidence interval 0.2, 0.9; p = 0.01). CONCLUSIONS: The observed positive association between integrated HIV-1 DNA load and frequency of CD8(+)DR/DP/DQ(+) cells indicates that a close correlation between HIV persistence and immune activation continues during consistently suppressive therapy. The inducers of the distinct activation profile warrant further investigation.
Keywords
Viral Load Suppression, WHO, Suppression, VLS, Reservoir, Persistence, nucleoside/nucleotide reverse transcriptase inhibitors, NRTI, PBMCs, NNRTI, Non-nucleoside reverse-transcriptase inhibitors, National Institute for Health Research, NIHR, LPS, lipopolysaccharide, Human Leukocyte Antigen, Integration, HLA, HIV-1, Human Immunodeficiency Virus type 1, HIV-1 viral load, HIV-1 controllers, HIV-1 VL, HIC, enzyme-linked immune-enzymatic assay, Epstein-Bar virus, ELISA, EBV, CRN, Clinical Research Network, cytomegalovirus virus, Activation, CMV, Anti-retroviral therapy, ART, 2-long terminal repeats, World Health Organisation, 2-LTR, Peripheral blood mononuclear cells, PCR, PFA, paraformaldehyde, Polymerase chain reaction, sCD14, soluble CD14

Downloads

  • ERAS Paper1.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 447.53 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Ruggiero, Alessandra, Ward De Spiegelaere, Alessandro Cozzi-Lepri, Maja Kiselinova, Georgios Pollakis, Apostolos Beloukas, Linos Vandekerckhove, et al. 2015. “During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood Is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ.” Ebiomedicine 2 (9): 1153–1159.
APA
Ruggiero, A., De Spiegelaere, W., Cozzi-Lepri, A., Kiselinova, M., Pollakis, G., Beloukas, A., Vandekerckhove, L., et al. (2015). During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ. EBIOMEDICINE, 2(9), 1153–1159.
Vancouver
1.
Ruggiero A, De Spiegelaere W, Cozzi-Lepri A, Kiselinova M, Pollakis G, Beloukas A, et al. During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ. EBIOMEDICINE. 2015;2(9):1153–9.
MLA
Ruggiero, Alessandra, Ward De Spiegelaere, Alessandro Cozzi-Lepri, et al. “During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood Is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ.” EBIOMEDICINE 2.9 (2015): 1153–1159. Print.
@article{6968618,
  abstract     = {BACKGROUND: Characterising the correlates of HIV persistence improves understanding of disease pathogenesis and guides the design of curative strategies. This study investigated factors associated with integrated HIV-1 DNA load during consistently suppressive first-line antiretroviral therapy (ART).
METHOD: Total, integrated, and 2-long terminal repeats (LTR) circular HIV-1 DNA, residual plasma HIV-1 RNA, T-cell activation markers, and soluble CD14 (sCD14) were measured in peripheral blood of 50 patients that had received 1-14 years of efavirenz-based or nevirapine-based therapy.
RESULTS: Integrated HIV-1 DNA load (per 10(6) peripheral blood mononuclear cells) was median 1.9 log10 copies (interquartile range 1.7-2.2) and showed a mean difference of 0.2 log10 copies per 10 years of suppressive ART (95\% confidence interval - 0.2, 0.6; p = 0.28). It was positively correlated with total HIV-1 DNA load and frequency of CD8(+)HLA-DR/DP/DQ(+) cells, and was also higher in subjects with higher sCD14 levels, but showed no correlation with levels of 2-LTR circular HIV-1 DNA and residual plasma HIV-1 RNA, or the frequency of CD4(+)CD38(+) and CD8(+)CD38(+) cells. Adjusting for pre-ART viral load, duration of suppressive ART, CD4 cell counts, residual plasma HIV-1 RNA levels, and sCD14 levels, integrated HIV-1 DNA load was mean 0.5 log10 copies higher for each 50\% higher frequency of CD8(+)HLA-DR/DP/DQ(+) cells (95\% confidence interval 0.2, 0.9; p = 0.01).
CONCLUSIONS: The observed positive association between integrated HIV-1 DNA load and frequency of CD8(+)DR/DP/DQ(+) cells indicates that a close correlation between HIV persistence and immune activation continues during consistently suppressive therapy. The inducers of the distinct activation profile warrant further investigation.},
  author       = {Ruggiero, Alessandra and De Spiegelaere, Ward and Cozzi-Lepri, Alessandro and Kiselinova, Maja and Pollakis, Georgios and Beloukas, Apostolos and Vandekerckhove, Linos and Strain, Matthew and Richman, Douglas and Phillips, Andrew and Geretti, Anna Maria},
  issn         = {2352-3964},
  journal      = {EBIOMEDICINE},
  keyword      = {Viral Load Suppression,WHO,Suppression,VLS,Reservoir,Persistence,nucleoside/nucleotide reverse transcriptase inhibitors,NRTI,PBMCs,NNRTI,Non-nucleoside reverse-transcriptase inhibitors,National Institute for Health Research,NIHR,LPS,lipopolysaccharide,Human Leukocyte Antigen,Integration,HLA,HIV-1,Human Immunodeficiency Virus type 1,HIV-1 viral load,HIV-1 controllers,HIV-1 VL,HIC,enzyme-linked immune-enzymatic assay,Epstein-Bar virus,ELISA,EBV,CRN,Clinical Research Network,cytomegalovirus virus,Activation,CMV,Anti-retroviral therapy,ART,2-long terminal repeats,World Health Organisation,2-LTR,Peripheral blood mononuclear cells,PCR,PFA,paraformaldehyde,Polymerase chain reaction,sCD14,soluble CD14},
  language     = {eng},
  number       = {9},
  pages        = {1153--1159},
  title        = {During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR/DP/DQ},
  url          = {http://dx.doi.org/10.1016/j.ebiom.2015.07.025},
  volume       = {2},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: